Targeting of the antivascular drug combretastatin to irradiated tumors results in tumor growth delay.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/C56CEF8F.svg?ark=w1%2F20260515%2FC56CEF8F)](https://nobleid.org/work/w1/20260515/C56CEF8F)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors